Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19.

Close, Ryan M; Jones, T Shaifer; Jentoft, Christopher; McAuley, James B

Close, Ryan M; Jones, T Shaifer; Jentoft, Christopher; McAuley, James B.

Close RM; Whiteriver Indian Hospital, Indian Health Service, Whiteriver, Arizona.
Jones TS; Whiteriver Indian Hospital, Indian Health Service, Whiteriver, Arizona.
Jentoft C; Whiteriver Indian Hospital, Indian Health Service, Whiteriver, Arizona.
McAuley JB; Whiteriver Indian Hospital, Indian Health Service, Whiteriver, Arizona.

JAMA Netw Open ; 4(9): e2125866, 2021 09 01.

Article in English | MEDLINE | ID: covidwho-1427026

Subject(s)

American Indian or Alaska Native; Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19 Drug Treatment; Hospital Mortality; Hospitalization; Adolescent; Adult; Arizona/epidemiology; COVID-19/mortality; Female; Hospitalization/statistics & numerical data; Humans; Male; Middle Aged; Pandemics; Retrospective Studies; Rural Population; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hospital Mortality / American Indian or Alaska Native / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment / Hospitalization Type of study: Observational study / Prognostic study Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google